Oxaliplatin is used in the management of certain types of gynecological cancers, including ovarian cancer. It is usually administered as part of a combination regimen with other drugs like paclitaxel or bevacizumab. The combination therapies are aimed at improving treatment outcomes and reducing the likelihood of drug resistance.
